HCHaimei Chen

Haimei Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haimei Chen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Jin Wang

    Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    2 shared publications
  • Yuanqiang Xiao

    Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    2 shared publications
  • An-Qi Li

    NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China

    1 shared publication
  • Bin Wu

    Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

    1 shared publication
  • Bingsheng Huang

    1 shared publication
  • Chao Li

    Department of Radiology, The Third Affiliated Hospital Sun Yat‐Sen University Guangzhou Guangdong China

    1 shared publication

Latest Publications

  • Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid–enhanced MRI: A Retrospective, Multicenter, Diagnostic Study

    by Mingkai Li, Zhi Zhang, Zebin Chen, Xi Chen, Huaqing Liu, Yuanqiang Xiao, Haimei Chen, Xiaodan Zong, Jingbiao Chen, Jianning Chen, et al.

    An artificial intelligence model developed using gadoxetic acid–enhanced MRI effectively diagnosed hepatocellular carcinoma. Radiologists assisted by the model, which included a post hoc Liver Imaging Reporting and Data System feature identification tool, had improved sensitivity.


  • Top Cited Papers

    Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma

    by Mengsi Li, Yaheng Fan, Huayu You, Chao Li, Ma Luo, Jing Zhou, Anqi Li, Lina Zhang, Xiao Yu, Weiwei Deng, et al.

    Background It is unknown whether the additional information provided by multiparametric dual-energy CT (DECT) could improve the noninvasive diagnosis of the aggressive macrotrabecular-massive (MTM) subtype of hepatocellular carcinoma (HCC). Purpose To evaluate the diagnostic performance of dual-phase contrast-enhanced multiparametric DECT for predicting MTM HCC. Materials and Methods Patients with histopathologic examination-confirmed HCC who underwent contrast-enhanced DECT between June 2019 and June 2022 were retrospectively recruited from three independent centers (center 1, training and internal test data set; centers 2 and 3, external test data set). Radiologic features were visually analyzed and combined with clinical information to establish a clinical-radiologic model. Deep learning (DL) radiomics models were based on DL features and handcrafted features extracted from virtual monoenergetic images and material composition images on dual phase using binary least absolute shrinkage and selection operators. A DL radiomics nomogram was developed using multivariable logistic regression analysis. Model performance was evaluated with the area under the receiver operating characteristic curve (AUC), and the log-rank test was used to analyze recurrence-free survival. Results A total of 262 patients were included (mean age, 54 years ± 12 [SD]; 225 men [86%]; training data set, n = 146 [56%]; internal test data set, n = 35 [13%]; external test data set, n = 81 [31%]). The DL radiomics nomogram better predicted MTM than the clinical-radiologic model (AUC = 0.91 vs 0.77, respectively, for the training set [P < .001], 0.87 vs 0.72 for the internal test data set [P = .04], and 0.89 vs 0.79 for the external test data set [P = .02]), with similar sensitivity (80% vs 87%, respectively; P = .63) and higher specificity (90% vs 63%; P < .001) in the external test data set. The predicted positive MTM groups based on the DL radiomics nomogram had shorter recurrence-free survival than predicted negative MTM groups in all three data sets (training data set, P = .04; internal test data set, P = .01; and external test data set, P = .03). Conclusion A DL radiomics nomogram derived from multiparametric DECT accurately predicted the MTM subtype in patients with HCC. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Chu and Fishman in this issue.